FOXO1 and clear cell renal carcinoma: ADAMTS9-AS2 inhibits cell proliferation via the miR-27a-3p/FOXO1 axis in clear cell renal cell carcinoma [52] and controls the chondrogenic differentiation in human mesenchymal stem cells through a ceRNA mechanism [53].